Effects of sigma receptor agonists on the impairment of spontaneous alternation behavior and decrease of cyclic GMP level induced by nitric oxide synthase inhibitors in mice

Neuropharmacology

Volumn 39, Issue 12, 2000, Pages 2391-2398

  Mamiya, Takayoshi ^a   Noda, Yukihiro ^a   Noda, Akihiro ^a   Hiramatsu, Masayuki ^b   Karasawa, Katsuhiro ^b   Kameyama, Tsutomu ^b,c   Furukawa, Shoei ^d   Yamada, Kiyofumi ^a   Nabeshima, Toshitaka ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MEIJO UNIVERSITY   (Japan)

^c Japan Inst of Psychopharmacology   (Japan)

^d GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Cyclic GMP; Nitric oxide synthase inhibitor; Nitric oxide cyclic GMP pathway; Sigma receptor agonists; Spontaneous alternation behavior

Indexed keywords

ALPHA (4 FLUOROPHENYL) 4 (5 FLUORO 2 PYRIMIDINYL) 1 PIPERAZINEBUTANOL; CYCLIC GMP; N ALLYLNORMETAZOCINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; PENTAZOCINE; SIGMA OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; ENZYME ACTIVITY; HIPPOCAMPUS; LEARNING; MALE; MAZE TEST; MEMORY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANALGESICS, OPIOID; ANIMALS; ANTI-ANXIETY AGENTS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; CYCLIC GMP; ENZYME INHIBITORS; GUANIDINES; INDAZOLES; MALE; METHYLENE BLUE; MICE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PENTAZOCINE; PHENAZOCINE; PYRIMIDINES; RECEPTORS, SIGMA;

EID: 0033884099     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(00)00078-2     Document Type: Article

References (42)

1. Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proceedings of the National Academy of Science USA. 86:1989;9030-9033.
2. Bannerman D.M., Chapman P.F., Kelly A.T., Butcher S.P., Morris R.G.M. Inhibition of nitric oxide synthase does not impair spatial learning. Journal of Neuroscience. 14:1994;7404-7414.
3. Chapman P.F., Atkins C.M., Allen M.T., Haley J.E., Steinmetz J.E. Inhibition of nitric oxide synthesis impairs two different forms of learning. NeuroReport. 3:1992;567-570.
4. Dawson T.M., Snyder S.H. Gases as biological messengers: Nitric oxide and carbon monoxide in the brain. Journal of Neuroscience. 14:1994;5147-5159.
5. Earley B., Burke M., Leonard B.E., Gouret C.J., Junien J.L. Evidence for anti-amnesic effect of JO-1784 in the rats: a potent and selective ligand for the NMDA receptor. Brain Research. 546:1991;282-286.
6. East S.J., Garthwaite J. NMDA receptors activation in rat hippocampus induces cyclic GMP formation through the L-arginine-nitric oxide pathway. Neuroscience Letters. 123:1991;17-19.
7. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates. 1997;Academic Press, San Diego.
8. Garthwaite J., Charles S.L., Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature. 336:1988;385-388.
9. Garthwaite J., Garthwaite G., Palmar R.M.J., Moncada S. NMDA receptors activation induces nitric oxide synthesis from arginine in rat brain slices. European Journal of Pharmacology. 172:1989;413-416.
10. 3H]dopa in various regions of the brain. Journal of Neurochemistry. 13:1966;655-669.
11. Guevara-Guzman R., Emson P.C., Kendrick K.M. Modulation of in vivo striatal transmitter release by nitric oxide and cyclic GMP. Journal of Neurochemistry. 62:1994;807-810.
12. 3H]-dopamine from striatal slices. NeuroReport. 3:1993;409-412.
13. 3H] acetylcholine release from rat hippocampal slices. European Journal of Pharmacology. 200:1991;343-345.
14. Knowles R.G., Palacios M., Palmar R.M.J., Moncada S. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proceedings of the National Academy of Science USA. 86:1989;5159-5162.
15. Lodge D., Johnson K.M. Noncompetitive excitatory amino acid receptor antagonists. Trends in Pharmacological Science. 11:1990;81-86.
16. Lowry O.H., Rosebrought N.J., Farr A.L., Randall R.J. Protein measurements with the folin phenol reagent. Journal of Biological Chemistry. 193:1951;265-275.
17. Manallack D.T., Beart P.M., Gundlach A.L. Psychotomimetic sigma-opiates and PCP. Trends in Pharmacological Science. 7:1986;448-451.
18. Martin W.R., Eades C.G., Thompson J.A., Huppler R.E., Gilbert P.E. The effect of morphine and morphine-like drugs in the non-dependent and morphine-dependent chronic spinal dog. Journal of Pharmacology, Experiment and Therapeutics. 197:1976;517-532.
19. Matsuno K., Matsunaga K., Senda T., Mita S. Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex. Journal of Pharmacology, Experiment and Therapeutics. 265:1993;851-859.
20. Matsuno K., Senda T., Matsunaga K., Mita S. Ameliorating effects of sigma receptor agonists on the passive avoidance tasks in mice: involvement in the central acetylcholinergic system. European Journal of Pharmacology. 261:1994;43-51.
21. 1 receptor agonistic properties. Behavioural Brain Research. 83:1997;221-224.
22. Maurice T., Hiramatsu M., Itoh J., Kameyama T., Hasegawa T., Nabeshima T. Behavioral evidence for a modulating role of sigma agonists in memory process (I). Attenuation of dizocilpine (MK-801)-induced amnesia. Brain Research. 647:1994;44-56.
23. 1 receptor agonist properties, facilitates NMDA receptor-dependent learning in mice. European Journal of Pharmacology. 328:1997;9-18.
24. 3H] noradrenaline release involve Gi/o proteins. Society of Neuroscience Abstracts. 17:1991;1340.
25. Monnet F.P., Debonnel G., De Montigny C. In vivo electrophysiological evidence for a selective modulation of N-Methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma agonists. Journal of Pharmacology, Experiment and Therapeutics. 261:1992;123-130.
26. Monnet F.P., Debonnel G., Junien J.-L., De Montigny C. N-Methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors. European Journal of Pharmacology. 179:1990;441-445.
27. Montague P.R., Gancayco C.D., Winn M.J., Marchase R.B., Friedlander M.J. Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science. 263:1994;973-977.
28. Ohno M., Watanabe S. Intrahippocampal administration of (+) SKF 10,047, a sigma ligand, reverses MK-801-induced impairment of working memory in rats. Brain Research. 684:1995;237-242.
29. 3H] dopamine uptake. Brain Research. 641:1994;83-91.
30. Quirion R., Chicheportiche R., Contreas P.C., Johnson K.M., Lodge D., Tam S.W., Woods J.H., Zukin S.R. Classification and nomenclature of phencyclidine and sigma receptor sites. Trends in Neuroscience. 10:1987;444-446.
31. Roman F.J., Pascaud X., Duffy O., Junien J.-L. Modulation by neuropeptide Y and peptide YY of NMDA effects in hippocampal slices: role of sigma receptors. Kameyama T., Nabeshima T., Domino E.F. NMDA Related Agents: Biochemistry, Pharmacology and Behavior. 1991;211 NPP Books, Ann Arbor.
32. Siniscalchi A., Cristofori P., Veratti E. Influence of N-allyl-normetazocine on acetylcholine release from brain slices: involvement of muscarinic receptors. Naunyn-Schmiedebergs Archives of Pharmacology. 336:1987;425-429.
33. Snyder S.H. Nitric oxide: first in a new class of neurotransmitters. Science. 257:1992;494-496.
34. Walker J.M., Bowen W.D., Walker F.O., Matsumoto R.R., De Costs B., Rice K.C. Sigma receptors: biology and function. Pharmacology Review. 42:1990;355-402.
35. Wieraszko A. Avian hippocampus as a model to study spatial orientation-related synaptic plasticity. Advances in Experimental Medicine and Biology. 446:1998;107-129.
36. 3H] MK-801 labels a site on the N-methyl-D-aspartate receptors channel complex in rat brain membranes. Journal of Neurochemistry. 50:1988;274-281.
37. Yamada K., Nabeshima T. Modulation of nitric oxide production in vivo in the brain. Methods of Finding in Experimental and Clinical Pharmacology. 20:1998;601-605.
38. Yamada K., Noda Y., Nakayama S., Komori Y., Sugihara H., Hasegawa T., Nabeshima T. Role of nitric oxide in learning and memory and monoamine metabolism in the rat brain. British Journal of Pharmacology. 115:1995;852-858.
39. Yamada K., Hiramatsu M., Noda Y., Mamiya T., Murai M., Kameyama T., Komori Y., Nikai T., Sugihara H., Nabeshima T. Role of nitric oxide and cyclic GMP in the dizocilpine-induced impairment of spontaneous alternation behavior in mice. Neuroscience. 74:1996;365-374.
40. Yamada K., Noda Y., Hasegawa T., Komori Y., Nikai T., Sugihara H., Nabeshima T. The role of nitric oxide in dizocilpine-induced impairment of spontaneous alternation behavior in mice. Journal of Pharmacology, Experiment and Therapeutics. 276:1996;460-466.
41. Zhu X., Luo L. Effects of nitroprusside (nitric oxide) on endogenous dopamine release from rat striatal slices. Journal of Neurochemistry. 59:1992;932-935.
42. Zou L.-B., Yamada K., Nabeshima T. Sigma receptor agonists (+) SKF 10,047 and SA4503 improve dizocilpine-induced spatial memory deficits in rats. European Journal of Pharmacology. 355:1998;1-10.